Currently exports to West Africa
Ahmedabad based Marck Biosciences Ltd, manufacturer of sterile dosages, that has developed Paracetamol IV in plastic pack, plans to launch it in India within the end of this year and is looking at generating business worth Rs 2crore from the new product.
The company has developed Paracetamol IV in plastic pack using blow-fill-seals(BFS) technology with an investment of around Rs 30 lakh. It currently manufactures the product at its Kheda facility near Ahmedabad and has started exporting it to countries in West Africa last month.
“We are expecting sales worth $1.1 million from exports by the end of this year”, said Bhavesh Patel, managing director, Marck Biosciences.
"Marck’s formulation and development team has been working on preparing and studying different formulations of Paracetamol IV for the past 3 years to come up with Paracetamol IV first time in plastic pack in the world", the company claimed in a statement. "Paracetamol IV in plastic will have lower freight costs and breakages and help in more competitive pricing in comparison to glass bottles,” Patel said.
Paracetamol IV is a ready to infuse dosage form of Paracetamol (in 10 mg/ml solution) and is indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever urgently when other routes of administration are not possible.Paracetamol IV is especially advantageous in non-sterile environments and aids greatly in safe delivery of the drug.
Marck manufactures and markets a range of sterile dosages spanning fluid therapy, ophthalmics, respiratory, irrigation solutions and anti-infectives across India and also contract manufactures sterile dosage pharma products for leading pharma companies in India.